The global medical imaging market size was valued at USD 28.02 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030. The increasing prevalence of lifestyle-related diseases, rising demand for early detection tools, technological advancements to improve turnaround time, increased investment & reimbursement initiatives undertaken by the government, and expansions of new facilities by market players in developing nations, are said to boost the market growth. For instance, in June 2021 the government of India launched X-Ray Setu, a free Artificial Intelligence (AI)-based platform to aid doctors with the early COVID-19 interventions. In 2022, Siemens Healthineers introduced a new CT scanner production unit in India, to fulfill the growing demand for CT scanners and boost its market position.
Moreover, in August 2020, Philips expanded its cardiovascular ultrasound portfolio by launching Affiniti CVx. The system is designed to help cardiology departments and provide better care to more patients while improving efficiency and throughput. Furthermore, in November 2021, Philips announced the launch of an AI-enabled MR imaging portfolio, which is intended to improve the efficiency and sustainability of radiology operations by speeding up MR exams. Such technological advancements are said to boost the market growth exponentially.
Increasing demand for state-of-the-art imaging modalities by teaching hospitals and universities to provide training for advanced technology is expected to have a significant impact on the market growth during the forecast years. Furthermore, the adoption of AI to automate image quantification and identification process is also expected to boost the market growth. For instance, Google’s AI platform, named, Google’s Deepmind collaborated with Moorfields Eye Hospital to read all eye scans performed using an optical CT scanner, to ensure early detection of age-related macular degeneration. In addition, the introduction of 3D MRI and CT scans enables radiologists to quickly analyze scans, reducing analysis time and improving efficacy.
Moreover, computer vision is being used to diagnose conditions, that are not visible to the human eye. Despite the technical improvements and increased adoption of advanced imaging tools, the market witnessed a decline due to the outbreak of the COVID-19 pandemic. Reduction of imaging volumes, economic setbacks leading to reduced adoption of advanced imaging equipment, reduced staff at radiology centers & hospitals, and increased adoption of teleradiology services, are factors impacting the drop in the market.
The computed tomography market experienced a surge as increased diagnosis of COVID-19-infected patients was conducted using CT scans. Market leaders like Siemens Healthineers stated that their sales volume for CT scanners doubled during the pandemic period, leading to the overall surge in the CT market. However, the market dropped significantly in 2020 but is expected to bounce back in 2022.
The ultrasound segment dominated the global market in 2021 and accounted for the largest share of more than 28.00% of the global revenue. The segment is expected to maintain its lead during the forecast period. The segment growth can be attributed to the rising number of ultrasound applications. Recent developments in advanced ultrasound transducers have opened new avenues for ultrasound devices in biomedical and cardiovascular imaging. Moreover, a high focus on the development of portable ultrasound devices is expected to expand the applications of this modality in ambulatory as well as emergency care. The integration of Artificial Intelligence (AI) into ultrasound systems to automate the process of image quantification and selection, is also expected to influence the market growth.
The CT segment is expected to witness the fastest CAGR during the forecast period. CT systems are one of the primary diagnostic tools for COVID-19 patients. High demand for Point of Care(POC) CT devices and the development of a high-precision CT scanner by the integration of AI & ML and advanced visualization systems are the principal factors driving the segment. In October 2019, Canon received the U.S. FDA nod for its Advanced Intelligent Clear-IQ Engine (AiCE), an AI technology for integration with its Aquilion Precision scanner. The technology helps in achieving precision diagnostic without the need to increase the dose. GE Healthcare, in March 2020, increased its manufacturing capacity by opening new production facilities, to meet the growing demand for advanced imaging tools, especially during the COVID-19 pandemic.
The hospital end-use segment dominated the global market in 2021 and accounted for the largest share of more than 47.00% of the overall revenue. Rising demand for advanced imaging modalities and the integration of surgical suits with imaging technologies are some of the factors driving the segment growth. Some of the countries in developed regions have shown a sharp rise in demand for these modalities in teaching hospitals as compared to general or special hospitals. However, developing countries in the Asia Pacific region have shown a steep rise in the number of new hospitals.
This can be attributed to the entry of multinational healthcare service providers. Healthcare service in these countries is dominated by private players. New hospitals generally provide dedicated space for imaging modalities. Rising competition and increasing demand for world-class healthcare services are the factors expected to fuel the segment growth in the coming years. The diagnostic imaging segment is estimated to mark the highest growth rate due to the increased adoption of advanced technology, improved infrastructure, and high funding for the growth of these centers.
North America dominated the overall market in 2021 and accounted for the largest share of more than 33.00% of the global revenue. The presence of a large number of industry players and the high frequency of new product launches within the region are the factors contributing to the regional market growth. The region exhibits high adoption of advanced, high-end medical imaging equipment due to favorable reimbursement scenarios and funding from market players. North America accounts for the highest spending on healthcare, in terms of GDP, with the U.S. spending nearly 19.7% of GDP on healthcare as of 2020.
The aforementioned factors, coupled with the increasing aging population, a rise in the cases of chronic diseases, and the growing trend of preventive diagnostic practices, are expected to drive the regional market. On the other hand, the regional market in the Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period owing to the rising incidences of chronic diseases and high demand for advanced imaging devices. An increasing number of local manufacturing units is expected to provide moderately-priced diagnostic units, thus helping in this price-sensitive, underpenetrated market space.
Recent trends of collaborations between local and global companies are expected to have a synergistic effect on market growth. Such collaborations and exchange of technologies help in speeding up the development and boosting the market competition, thus providing sophisticated yet affordable imaging systems. Such collaborations are not limited to diagnostic imaging players. The integration of imaging modalities with advanced surgical suit manufacturers is expected to have a positive effect on the diagnostic imaging market growth as well as on robot-assisted surgery systems.Some prominent players in the global medical imaging market include:
GE Healthcare
Koninklijke Philips N.V.
Siemens Healthineers
Canon Medical Systems Corp.
Mindray Medical International
Esaote
Hologic, Inc.
Samsung Medison Co., Ltd.
Koning Corporation
PerkinElmer Inc.
FUJIFILM VisualSonics Inc.
Cubresa Inc.
Report Attribute |
Details |
Market size value in 2022 |
USD 32.33 billion |
Revenue forecast in 2030 |
USD 47.4 billion |
Growth rate |
CAGR of 4.9% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2018 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Mexico; Brazil; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
GE Healthcare; Koninklijke Philips N.V.; Siemens Healthineers; Koninklijke Philips N.V., Canon Medical Systems Corporation, Mindray Medical International, Esaote, Hologic, Inc., Samsung Medison Co., Ltd., Koning Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc., Cubresa Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global medical imaging market report based on product, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
X-ray
By Modality
Radiography
Fluoroscopy
Mammography
By Technology
Digital Radiography
Computed Radiography
By Mobility
Stationary
Mobile
By End-use
Hospital
Diagnostic Imaging Centers
Others
Ultrasound
By Product
Diagnostic ultrasound devices
2D
3D/4D
Doppler
Therapeutic ultrasound devices
High-intensity focused ultrasound
Extracorporeal shock wave lithotripsy
By Portability
Handheld
Cart/Trolley Based
By Application
Ob/Gyn
Cardiology
Vascular
Orthopedics
General Imaging
By End-use
Hospital
Diagnostic Imaging Centers
Others
Computed Tomography
By Technology
High-end slice
Mid end slice
Low-end slice
Cone beam
By Application
Oncology
Neurology
Cardiology
Vascular
Musculoskeletal
Others
By End-use
Hospital
Diagnostic Imaging Centers
Others
Magnetic Resonance Imaging (MRI)
By Architecture
Closed System
Open System
By Field Strength
Low Field Strength
Mid Field Strength
High Field Strength
By Application
Brain and neurological
Spine and musculoskeletal
Vascular
Abdomen
Cardiac
Breast
Other
By End-use
Hospital
Diagnostic Imaging Centers
Others
Nuclear Imaging
By Product
SPECT
Analog
Digital
Software
Equipment
PET
Analog
Digital
Software
Equipment
By Application
Oncology
Cardiology
Neurology
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostic Imaging Centers
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
Japan
India
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global medical imaging market size was estimated at USD 28.02 billion in 2021 and is expected to reach USD 32.33 billion in 2022.
b. The global medical imaging market is expected to grow at a compound annual growth rate of 4.9% from 2022 to 2030 to reach USD 47.4 billion by 2030.
b. North America dominated the medical imaging market with a share of 33.4% in 2021. This is attributable to the presence of a large number of industry players and the high frequency of new product launches within the region.
b. Some key players operating in the medical imaging market include GE Healthcare; Koninklijke Philips N.V.; Siemens Healthineers; Canon Medical Systems Corporation; Mindray Medical International; Esaote.; Hologic; Samsung MedisonCo., Ltd. , Koning Coporation; Perkin Elmer; FUJIFILM VisualSonics Inc.; Cubresa Inc.
b. Key factors that are driving the medical imaging market growth include increasing prevalence of lifestyle-related diseases, rising demand for early detection tools, technological advancements to improve turnaround time, increased investment and reimbursement initiatives undertaken by the government
b. Hospitals accounted for the largest share of 47.3% in the end-use segment of the medical imaging market in 2021.
b. The CT segment is expected to witness the fastest growth in the medical imaging market through 2028, as there is high in demand for point-of-care CT devices and the development of a high-precision CT scanner by the integration of AI & ML and advanced visualization systems
b. In October 2019, Canon received the U.S. FDA approval for its Advanced Intelligent Clear-IQ Engine (AiCE), an AI technology for integration with its Aquilion Precision scanner, for achieving precision diagnostic without increasing the dosage.
b. The high spending on healthcare with regards to GDP in the region, coupled with the increasing aging population and the rising incidences of chronic diseases, have aided in the positive development of the North American medical imaging market.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.